Adenoma and biliary cystadenoma

Kevin C. Soares, Andrew J. Page, Ihab R Kamel, Timothy M. Pawlik

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Hepatic adenomas are rare liver tumors whose pathomolecular classification distinguishes it from other hepatic lesions and directly impacts its clinical course. The incidence of hepatic adenomas is about 0.1 per 100,000 in non-oral contraceptive users versus 4 per 100,000 in oral contraceptive users. Biliary cystadenomas are rare epithelial tumors which account for less than 5 % of all cystic liver lesions. Although benign, both hepatic adenomas and biliary cystadenomas have malignant potential and can progress to hepatocellular carcinoma and biliary cystadenocarcinoma, respectively. More liberal use of cross-sectional imaging has led to increased diagnosis of both neoplasms. A careful and thorough diagnostic evaluation is necessary. Appropriate management consists of complete surgical excision and obtaining negative margins in order to lower the likelihood of recurrent or residual neoplastic disease. We describe the incidence, etiology, clinical presentation, and therapy of both lesions with a particular emphasis on appropriate management of these rare liver neoplasms.

Original languageEnglish (US)
Title of host publicationBenign Tumors of the Liver
PublisherSpringer International Publishing
Pages183-194
Number of pages12
ISBN (Print)9783319129853, 9783319129846
DOIs
StatePublished - Jan 1 2015

Fingerprint

Cystadenoma
Adenoma
Liver
Tumors
Oral Contraceptives
Contraceptive Agents
Cystadenocarcinoma
Imaging techniques
Neoplasms
Incidence
Liver Neoplasms
Hepatocellular Carcinoma

Keywords

  • Adenoma
  • Biliary cyst
  • Liver cyst

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Soares, K. C., Page, A. J., Kamel, I. R., & Pawlik, T. M. (2015). Adenoma and biliary cystadenoma. In Benign Tumors of the Liver (pp. 183-194). Springer International Publishing. https://doi.org/10.1007/978-3-319-12985-3_14

Adenoma and biliary cystadenoma. / Soares, Kevin C.; Page, Andrew J.; Kamel, Ihab R; Pawlik, Timothy M.

Benign Tumors of the Liver. Springer International Publishing, 2015. p. 183-194.

Research output: Chapter in Book/Report/Conference proceedingChapter

Soares, KC, Page, AJ, Kamel, IR & Pawlik, TM 2015, Adenoma and biliary cystadenoma. in Benign Tumors of the Liver. Springer International Publishing, pp. 183-194. https://doi.org/10.1007/978-3-319-12985-3_14
Soares KC, Page AJ, Kamel IR, Pawlik TM. Adenoma and biliary cystadenoma. In Benign Tumors of the Liver. Springer International Publishing. 2015. p. 183-194 https://doi.org/10.1007/978-3-319-12985-3_14
Soares, Kevin C. ; Page, Andrew J. ; Kamel, Ihab R ; Pawlik, Timothy M. / Adenoma and biliary cystadenoma. Benign Tumors of the Liver. Springer International Publishing, 2015. pp. 183-194
@inbook{6d0a16c97c504a1688ee72174e4770e9,
title = "Adenoma and biliary cystadenoma",
abstract = "Hepatic adenomas are rare liver tumors whose pathomolecular classification distinguishes it from other hepatic lesions and directly impacts its clinical course. The incidence of hepatic adenomas is about 0.1 per 100,000 in non-oral contraceptive users versus 4 per 100,000 in oral contraceptive users. Biliary cystadenomas are rare epithelial tumors which account for less than 5 {\%} of all cystic liver lesions. Although benign, both hepatic adenomas and biliary cystadenomas have malignant potential and can progress to hepatocellular carcinoma and biliary cystadenocarcinoma, respectively. More liberal use of cross-sectional imaging has led to increased diagnosis of both neoplasms. A careful and thorough diagnostic evaluation is necessary. Appropriate management consists of complete surgical excision and obtaining negative margins in order to lower the likelihood of recurrent or residual neoplastic disease. We describe the incidence, etiology, clinical presentation, and therapy of both lesions with a particular emphasis on appropriate management of these rare liver neoplasms.",
keywords = "Adenoma, Biliary cyst, Liver cyst",
author = "Soares, {Kevin C.} and Page, {Andrew J.} and Kamel, {Ihab R} and Pawlik, {Timothy M.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/978-3-319-12985-3_14",
language = "English (US)",
isbn = "9783319129853",
pages = "183--194",
booktitle = "Benign Tumors of the Liver",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Adenoma and biliary cystadenoma

AU - Soares, Kevin C.

AU - Page, Andrew J.

AU - Kamel, Ihab R

AU - Pawlik, Timothy M.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Hepatic adenomas are rare liver tumors whose pathomolecular classification distinguishes it from other hepatic lesions and directly impacts its clinical course. The incidence of hepatic adenomas is about 0.1 per 100,000 in non-oral contraceptive users versus 4 per 100,000 in oral contraceptive users. Biliary cystadenomas are rare epithelial tumors which account for less than 5 % of all cystic liver lesions. Although benign, both hepatic adenomas and biliary cystadenomas have malignant potential and can progress to hepatocellular carcinoma and biliary cystadenocarcinoma, respectively. More liberal use of cross-sectional imaging has led to increased diagnosis of both neoplasms. A careful and thorough diagnostic evaluation is necessary. Appropriate management consists of complete surgical excision and obtaining negative margins in order to lower the likelihood of recurrent or residual neoplastic disease. We describe the incidence, etiology, clinical presentation, and therapy of both lesions with a particular emphasis on appropriate management of these rare liver neoplasms.

AB - Hepatic adenomas are rare liver tumors whose pathomolecular classification distinguishes it from other hepatic lesions and directly impacts its clinical course. The incidence of hepatic adenomas is about 0.1 per 100,000 in non-oral contraceptive users versus 4 per 100,000 in oral contraceptive users. Biliary cystadenomas are rare epithelial tumors which account for less than 5 % of all cystic liver lesions. Although benign, both hepatic adenomas and biliary cystadenomas have malignant potential and can progress to hepatocellular carcinoma and biliary cystadenocarcinoma, respectively. More liberal use of cross-sectional imaging has led to increased diagnosis of both neoplasms. A careful and thorough diagnostic evaluation is necessary. Appropriate management consists of complete surgical excision and obtaining negative margins in order to lower the likelihood of recurrent or residual neoplastic disease. We describe the incidence, etiology, clinical presentation, and therapy of both lesions with a particular emphasis on appropriate management of these rare liver neoplasms.

KW - Adenoma

KW - Biliary cyst

KW - Liver cyst

UR - http://www.scopus.com/inward/record.url?scp=84944517697&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944517697&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-12985-3_14

DO - 10.1007/978-3-319-12985-3_14

M3 - Chapter

AN - SCOPUS:84944517697

SN - 9783319129853

SN - 9783319129846

SP - 183

EP - 194

BT - Benign Tumors of the Liver

PB - Springer International Publishing

ER -